đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
The purpose of this study is to evaluate the safety of sIPVs of different d...
Status
Completed
Location
Pizhou City Center for Disease Control and Prevention
Start Date
2016-10
Trial ID
NCT02985320
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
The purpose of this study is to conduct long-term surveillance for efficacy...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-18
Trial ID
NCT02207816
Sabin 2 will be withdrawn from routine use globally from April 2016 as per ...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02521974
Treatments Being Tested
Based on pre-clinical trial and phase 1 and phase 2 clinical data and princ...
Status
Completed
Location
Pingle Center for Disease Prevention and Control
Start Date
2012-01
Trial ID
NCT01510366
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
This first-in-human (FIH) phase 1 study is designed to evaluate in containe...
Status
Completed
Location
university of Antwerp - centre for the evaluation of vaccination
Start Date
2017-05-16
Trial ID
NCT03430349
Treatments Being Tested
With the progress of the eradication of polio, bivalent oral attenuated liv...
Status
Completed
Location
Guangxi Provincial Center for Diseases Control and Prevention
Start Date
2015-09-15
Trial ID
NCT03614702
Treatments Being Tested
The purpose of this study is to select the optimal antigen dosage of the th...
Status
Terminated
Location
CEVAXIN - David
Start Date
2017-06-07
Trial ID
NCT03092791
Treatments Being Tested